- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/60 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 277/60
Total number of patents in this class: 192
10-year publication summary
|
16
|
13
|
21
|
12
|
9
|
9
|
9
|
7
|
9
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| EyePoint Pharmaceuticals, Inc. | 101 |
10 |
| Piramal Enterprises Limited | 156 |
8 |
| LG Chem, Ltd. | 17635 |
6 |
| Boehringer Ingelheim International GmbH | 4642 |
6 |
| Ligand Pharmaceuticals Incorporated | 171 |
6 |
| Bristol-myers Squibb Company | 4880 |
5 |
| Takeda Pharmaceutical Company Limited | 2708 |
5 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 829 |
5 |
| The Regents of the University of California | 19961 |
4 |
| Duke University | 3069 |
4 |
| Chaperone Therapeutics, Inc | 5 |
4 |
| PGI Drug Discovery LLC | 33 |
4 |
| Rohm and Haas Electronic Materials Korea Ltd. | 330 |
4 |
| Sunovion Pharmaceuticals Inc. | 266 |
4 |
| Merck Sharp & Dohme Corp. | 2191 |
3 |
| CHDI Foundation, Inc. | 106 |
3 |
| Connexios Life Sciences Pvt. Ltd. | 12 |
3 |
| Kymera Therapeutics, Inc. | 232 |
3 |
| Abbott Laboratories | 2402 |
2 |
| FUJIFILM Corporation | 29437 |
2 |
| Other owners | 101 |